Determining the appropriate retatrutide quantity is crucial for achieving desired effects. Initially, several patients commence with a modest measurement of approximately 2.4 mg, given every week. This initial amount is then incrementally increased based on individual response and glycemic control. The maximum recommended dose generally caps at 10.